UTI Asset Management Company Limited (UTI AMC) has announced that its Board of Directors has recommended a final dividend of ₹48 per equity share for the financial year ended March 31, 2025. This comprehensive dividend comprises a normal dividend of ₹26 per equity share and a special dividend of ₹22 per equity share. The recommendation is subject to the approval of shareholders at the company's upcoming 22nd Annual General Meeting (AGM), scheduled for Thursday, July 31, 2025.
| Particulars | Details |
|---|---|
| Normal Dividend per share | ₹26.00 (260% of face value ₹10) |
| Special Dividend per share | ₹22.00 (220% of face value ₹10) |
| Total Recommended Dividend per share | ₹48.00 (480% of face value ₹10) |
| Financial Year | 2024-25 |
| Record Date for Dividend | July 24, 2025 |
| Book Closure Period | July 25, 2025 to July 31, 2025 (inclusive) |
| AGM Date for Approval | July 31, 2025 |
Dividend Details and Approval Process
The recommended final dividend of ₹48 per equity share for FY 2024-25 represents a significant payout to shareholders, equivalent to 480% of the face value of ₹10 per equity share. This includes a normal dividend component of ₹26 per share and a special dividend of ₹22 per share. The declaration of this dividend is contingent upon the approval of the company's members at the 22nd Annual General Meeting. Once approved, the dividend will be paid to eligible shareholders whose names appear in the register of members or list of beneficial owners as of the close of business hours on the record date.Annual General Meeting and Key Agenda
The 22nd Annual General Meeting of UTI Asset Management Company Limited is scheduled to be held on Thursday, July 31, 2025, at 1600 hrs IST. The meeting will be conducted through Video Conferencing (VC) / Other Audio Visual Means (OAVM), in compliance with the Companies Act, 2013, SEBI Listing Regulations, and relevant circulars from the Ministry of Corporate Affairs and SEBI. The AGM agenda includes several key items for shareholder consideration and approval:- To receive, consider, and adopt the audited standalone financial statements of the Company for the financial year ended March 31, 2025, along with the directors' report and auditor's report thereon.
- To receive, consider, and adopt the audited consolidated financial statements of the Company for the financial year ended March 31, 2025, along with the auditor's report thereon.
- To declare the final dividend on equity shares for the financial year ended March 31, 2025, as recommended by the Board of Directors.
- To re-appoint Mr. Srivatsa Desikamani (DIN: 10193489), who retires by rotation, as a Non-Executive Nominee Director. Mr. Desikamani, representing T. Rowe Price International Ltd, is eligible for re-appointment and has consented to act as a Director.



